Operability versus Resectability in Non-Small Cell Lung Cancer: A Multidisciplinary Perspective

Zhao J, Wang H. Differential diagnostic value of 18F-FDG PET/CT in pulmonary carcinoids versus hamartomas. Acad Radiol. 2022;29 Suppl 2:S41-S46. doi:10.1016/j.acra.2020.10.022

Veccia A, Kinspergher S, Dipasquale M, Caffo O. Management of brain metastases from lung cancer in the era of immunotherapy: a review of the literature. Future Oncol. 2021;17:597-609. doi:10.2217/fon-2020-0701

Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer. Chest. 2013;143:e142S-e165S. doi:10.1378/chest.12-2353.

Vansteenkiste J, Crinò L, Dooms C, Douillard JY, Fraive-Finn C, Lim E, et al. Early-Stage NSCLC Consensus on Diagnosis, Treatment and Follow-up. Ann Oncol. 2014;25:1462-74. doi:10.1093/annonc/mdu089.

Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 NSCLC. Ann Thorac Surg. 1995;60:615-23. doi:10.1016/0003-4975(95)00537-U.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Fraive-Finn C, et al. Metastatic NSCLC: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29:iv192-iv237. doi:10.1093/annonc/mdy275.

Eberhardt WE, De Ruysscher D, Weder W, Péchoux CL, De Leyn P, Hoffmann H, et al. Locally Advanced Stage III NSCLC. Ann Oncol. 2015;26:1573-88. doi:10.1093/annonc/mdv187.

Faccioli E, Terzi S, Pangoni A, Lomangino I, Rossi S, Lloret A, et al. Extracorporeal membrane oxygenation in lung transplantation: Indications, techniques and results. World J Transplant. 2021;11:290-302. doi: 10.5500/wjt.v11.i7.290.

Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized NSCLC. J Thorac Cardiovasc Surg. 2006;132:769-75. doi:10.1016/j.jtcvs.2006.02.063

Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. Segmentectomy Versus Lobectomy in Small Peripheral NSCLC (JCOG0802/WJOG4607L). Lancet. 2022;399:1607-17. doi:10.1016/S0140-6736(21)02333-3